GENE ONLINE|News &
Opinion
Blog

AAV Vectors
Harnessing Viral Evolution to Deliver Gene Therapy to Specific Tissues
2021-09-13
Biogen Inks $120 Million Pact with High Flying Ginkgo Bioworks to Redefine Manufacturing of Gene Therapy Vectors
2021-05-23
The Transformative Potential of Gene Therapies for Hemophilia
2021-04-08
Overview of the Gene Therapy Revolution: Hopeful Beginnings, Tribulations, and Resurgence
2021-03-23
Jaguar Launches with a Pre-clinical Pipeline of AAV9-Based Gene Therapies
2021-02-28
Sanofi Joins Hands with German Biotech to Develop Improved AAV Capsids for Gene Therapies
2021-02-28
Ensoma Enters Gene-Editing Market with $70 Million Funding and Takeda Partnership
2021-02-12
Is Bayer’s Entry to the Gene Therapy Market Worth it’s Investment?
2020-10-27
Pfizer, Sangamo Dose First Hemophilia A Patient in Phase 3 with Gene Therapy Candidate
2020-10-08
Novartis Enters $75 Million Collaboration with Sangamo for its Zinc Finger Gene Editing Technology
2020-08-01
Daiichi Sankyo Invests in Ultragenyx’s Technology to Bolster Gene Therapy Pipeline
2020-04-02
LATEST
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top